Loading…

Response to Crizotinib in a Patient With Lung Adenocarcinoma Harboring a MET Splice Site Mutation

Saved in:

Bibliographic Details
Published in:	Clinical lung cancer 2015-09, Vol.16 (5), p.e101-e104
Main Authors:	Jenkins, Russell W, Oxnard, Geoffrey R, Elkin, Sheryl, Sullivan, E. Kelly, Carter, Jennifer L, Barbie, David A
Format:	Article
Language:	English
Subjects:	Adenocarcinoma - drug therapy Adenocarcinoma - genetics Adenocarcinoma - pathology Adenocarcinoma of Lung Aged, 80 and over Antineoplastic Agents - therapeutic use Crizotinib Hematology, Oncology and Palliative Medicine Humans Lung adenocarcinoma Lung Neoplasms - drug therapy Lung Neoplasms - genetics Lung Neoplasms - pathology Male MET Mutation Protein Kinase Inhibitors - therapeutic use Proto-Oncogene Proteins c-met - genetics Pulmonary/Respiratory Pyrazoles - therapeutic use Pyridines - therapeutic use RNA Splice Sites Splice site mutation Treatment Outcome
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by	cdi_FETCH-LOGICAL-c580t-dfec3683510af8270cf132da4de90bff72c5cc12c595be889d235ed756946b5f3
cites	cdi_FETCH-LOGICAL-c580t-dfec3683510af8270cf132da4de90bff72c5cc12c595be889d235ed756946b5f3
container_end_page	e104
container_issue	5
container_start_page	e101
container_title	Clinical lung cancer
container_volume	16
creator	Jenkins, Russell W Oxnard, Geoffrey R Elkin, Sheryl Sullivan, E. Kelly Carter, Jennifer L Barbie, David A
description
doi_str_mv	10.1016/j.cllc.2015.01.009
format	article
fullrecord	<record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4529392</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1525730415000534</els_id><sourcerecordid>1706209336</sourcerecordid><originalsourceid>FETCH-LOGICAL-c580t-dfec3683510af8270cf132da4de90bff72c5cc12c595be889d235ed756946b5f3</originalsourceid><addsrcrecordid>eNp9kkFv1DAQhSMEoqXwBzggH7kkjO04iSVUqVoVirQViC3iaDnOpPWStbe2U6n8ehxtqYADF9vSvPc8mm-K4jWFigJt3m0rM02mYkBFBbQCkE-KYyp5V0Ij4Wl-CybKlkN9VLyIcQvAGk7Z8-KIibaRHbTHhf6Kce9dRJI8WQX70yfrbE-sI5p80cmiS-S7TTdkPbtrcjag80YHY53faXKhQ--DzQVNLs-vyGY_WYNkYxOSyzllu3cvi2ejniK-erhPim8fzq9WF-X688dPq7N1aUQHqRxGNLzpuKCgx461YEbK2aDrASX049gyI4yh-ZSix66TA-MCh1Y0sm56MfKT4vSQu5_7HQ4mNx70pPbB7nS4V15b9XfF2Rt17e9ULZjkkuWAtw8Bwd_OGJPa2WhwmrRDP0dFW2gYSM6bLGUHqQk-xoDj4zcU1MJGbdXCRi1sFFCV2WTTmz8bfLT8hpEF7w8CzGO6sxhUNHn-Bgcb0CQ1ePv__NN_7GbKLI2efuA9xq2fg8sAFFWRKVCbZTuW5aACAASv-S_p_bYW</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1706209336</pqid></control><display><type>article</type><title>Response to Crizotinib in a Patient With Lung Adenocarcinoma Harboring a MET Splice Site Mutation</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Jenkins, Russell W ; Oxnard, Geoffrey R ; Elkin, Sheryl ; Sullivan, E. Kelly ; Carter, Jennifer L ; Barbie, David A</creator><creatorcontrib>Jenkins, Russell W ; Oxnard, Geoffrey R ; Elkin, Sheryl ; Sullivan, E. Kelly ; Carter, Jennifer L ; Barbie, David A</creatorcontrib><identifier>ISSN: 1525-7304</identifier><identifier>EISSN: 1938-0690</identifier><identifier>DOI: 10.1016/j.cllc.2015.01.009</identifier><identifier>PMID: 25769807</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adenocarcinoma - drug therapy ; Adenocarcinoma - genetics ; Adenocarcinoma - pathology ; Adenocarcinoma of Lung ; Aged, 80 and over ; Antineoplastic Agents - therapeutic use ; Crizotinib ; Hematology, Oncology and Palliative Medicine ; Humans ; Lung adenocarcinoma ; Lung Neoplasms - drug therapy ; Lung Neoplasms - genetics ; Lung Neoplasms - pathology ; Male ; MET ; Mutation ; Protein Kinase Inhibitors - therapeutic use ; Proto-Oncogene Proteins c-met - genetics ; Pulmonary/Respiratory ; Pyrazoles - therapeutic use ; Pyridines - therapeutic use ; RNA Splice Sites ; Splice site mutation ; Treatment Outcome</subject><ispartof>Clinical lung cancer, 2015-09, Vol.16 (5), p.e101-e104</ispartof><rights>Elsevier Inc.</rights><rights>2015 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c580t-dfec3683510af8270cf132da4de90bff72c5cc12c595be889d235ed756946b5f3</citedby><cites>FETCH-LOGICAL-c580t-dfec3683510af8270cf132da4de90bff72c5cc12c595be889d235ed756946b5f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25769807$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jenkins, Russell W</creatorcontrib><creatorcontrib>Oxnard, Geoffrey R</creatorcontrib><creatorcontrib>Elkin, Sheryl</creatorcontrib><creatorcontrib>Sullivan, E. Kelly</creatorcontrib><creatorcontrib>Carter, Jennifer L</creatorcontrib><creatorcontrib>Barbie, David A</creatorcontrib><title>Response to Crizotinib in a Patient With Lung Adenocarcinoma Harboring a MET Splice Site Mutation</title><title>Clinical lung cancer</title><addtitle>Clin Lung Cancer</addtitle><subject>Adenocarcinoma - drug therapy</subject><subject>Adenocarcinoma - genetics</subject><subject>Adenocarcinoma - pathology</subject><subject>Adenocarcinoma of Lung</subject><subject>Aged, 80 and over</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Crizotinib</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Lung adenocarcinoma</subject><subject>Lung Neoplasms - drug therapy</subject><subject>Lung Neoplasms - genetics</subject><subject>Lung Neoplasms - pathology</subject><subject>Male</subject><subject>MET</subject><subject>Mutation</subject><subject>Protein Kinase Inhibitors - therapeutic use</subject><subject>Proto-Oncogene Proteins c-met - genetics</subject><subject>Pulmonary/Respiratory</subject><subject>Pyrazoles - therapeutic use</subject><subject>Pyridines - therapeutic use</subject><subject>RNA Splice Sites</subject><subject>Splice site mutation</subject><subject>Treatment Outcome</subject><issn>1525-7304</issn><issn>1938-0690</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp9kkFv1DAQhSMEoqXwBzggH7kkjO04iSVUqVoVirQViC3iaDnOpPWStbe2U6n8ehxtqYADF9vSvPc8mm-K4jWFigJt3m0rM02mYkBFBbQCkE-KYyp5V0Ij4Wl-CybKlkN9VLyIcQvAGk7Z8-KIibaRHbTHhf6Kce9dRJI8WQX70yfrbE-sI5p80cmiS-S7TTdkPbtrcjag80YHY53faXKhQ--DzQVNLs-vyGY_WYNkYxOSyzllu3cvi2ejniK-erhPim8fzq9WF-X688dPq7N1aUQHqRxGNLzpuKCgx461YEbK2aDrASX049gyI4yh-ZSix66TA-MCh1Y0sm56MfKT4vSQu5_7HQ4mNx70pPbB7nS4V15b9XfF2Rt17e9ULZjkkuWAtw8Bwd_OGJPa2WhwmrRDP0dFW2gYSM6bLGUHqQk-xoDj4zcU1MJGbdXCRi1sFFCV2WTTmz8bfLT8hpEF7w8CzGO6sxhUNHn-Bgcb0CQ1ePv__NN_7GbKLI2efuA9xq2fg8sAFFWRKVCbZTuW5aACAASv-S_p_bYW</recordid><startdate>20150901</startdate><enddate>20150901</enddate><creator>Jenkins, Russell W</creator><creator>Oxnard, Geoffrey R</creator><creator>Elkin, Sheryl</creator><creator>Sullivan, E. Kelly</creator><creator>Carter, Jennifer L</creator><creator>Barbie, David A</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150901</creationdate><title>Response to Crizotinib in a Patient With Lung Adenocarcinoma Harboring a MET Splice Site Mutation</title><author>Jenkins, Russell W ; Oxnard, Geoffrey R ; Elkin, Sheryl ; Sullivan, E. Kelly ; Carter, Jennifer L ; Barbie, David A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c580t-dfec3683510af8270cf132da4de90bff72c5cc12c595be889d235ed756946b5f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adenocarcinoma - drug therapy</topic><topic>Adenocarcinoma - genetics</topic><topic>Adenocarcinoma - pathology</topic><topic>Adenocarcinoma of Lung</topic><topic>Aged, 80 and over</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Crizotinib</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Lung adenocarcinoma</topic><topic>Lung Neoplasms - drug therapy</topic><topic>Lung Neoplasms - genetics</topic><topic>Lung Neoplasms - pathology</topic><topic>Male</topic><topic>MET</topic><topic>Mutation</topic><topic>Protein Kinase Inhibitors - therapeutic use</topic><topic>Proto-Oncogene Proteins c-met - genetics</topic><topic>Pulmonary/Respiratory</topic><topic>Pyrazoles - therapeutic use</topic><topic>Pyridines - therapeutic use</topic><topic>RNA Splice Sites</topic><topic>Splice site mutation</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jenkins, Russell W</creatorcontrib><creatorcontrib>Oxnard, Geoffrey R</creatorcontrib><creatorcontrib>Elkin, Sheryl</creatorcontrib><creatorcontrib>Sullivan, E. Kelly</creatorcontrib><creatorcontrib>Carter, Jennifer L</creatorcontrib><creatorcontrib>Barbie, David A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical lung cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jenkins, Russell W</au><au>Oxnard, Geoffrey R</au><au>Elkin, Sheryl</au><au>Sullivan, E. Kelly</au><au>Carter, Jennifer L</au><au>Barbie, David A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Response to Crizotinib in a Patient With Lung Adenocarcinoma Harboring a MET Splice Site Mutation</atitle><jtitle>Clinical lung cancer</jtitle><addtitle>Clin Lung Cancer</addtitle><date>2015-09-01</date><risdate>2015</risdate><volume>16</volume><issue>5</issue><spage>e101</spage><epage>e104</epage><pages>e101-e104</pages><issn>1525-7304</issn><eissn>1938-0690</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>25769807</pmid><doi>10.1016/j.cllc.2015.01.009</doi><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 1525-7304
ispartof	Clinical lung cancer, 2015-09, Vol.16 (5), p.e101-e104
issn	1525-7304 1938-0690
language	eng
recordid	cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4529392
source	ScienceDirect Freedom Collection 2022-2024
subjects	Adenocarcinoma - drug therapy Adenocarcinoma - genetics Adenocarcinoma - pathology Adenocarcinoma of Lung Aged, 80 and over Antineoplastic Agents - therapeutic use Crizotinib Hematology, Oncology and Palliative Medicine Humans Lung adenocarcinoma Lung Neoplasms - drug therapy Lung Neoplasms - genetics Lung Neoplasms - pathology Male MET Mutation Protein Kinase Inhibitors - therapeutic use Proto-Oncogene Proteins c-met - genetics Pulmonary/Respiratory Pyrazoles - therapeutic use Pyridines - therapeutic use RNA Splice Sites Splice site mutation Treatment Outcome
title	Response to Crizotinib in a Patient With Lung Adenocarcinoma Harboring a MET Splice Site Mutation
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T06%3A53%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Response%20to%20Crizotinib%20in%20a%20Patient%20With%20Lung%20Adenocarcinoma%20Harboring%20a%20MET%20Splice%20Site%20Mutation&rft.jtitle=Clinical%20lung%20cancer&rft.au=Jenkins,%20Russell%20W&rft.date=2015-09-01&rft.volume=16&rft.issue=5&rft.spage=e101&rft.epage=e104&rft.pages=e101-e104&rft.issn=1525-7304&rft.eissn=1938-0690&rft_id=info:doi/10.1016/j.cllc.2015.01.009&rft_dat=%3Cproquest_pubme%3E1706209336%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c580t-dfec3683510af8270cf132da4de90bff72c5cc12c595be889d235ed756946b5f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1706209336&rft_id=info:pmid/25769807&rfr_iscdi=true